Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.

Barkas F, Elisaf M, Korantzopoulos P, Tsiara S, Liberopoulos E.

Int J Cardiol. 2017 Aug 15;241:194-199. doi: 10.1016/j.ijcard.2017.04.062. Epub 2017 Apr 20.

PMID:
28442233
2.

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study.

Kei A, Elisaf M, Moutzouri E, Tsiara S, Liberopoulos E.

Int J Hypertens. 2011;2011:830434. doi: 10.4061/2011/830434. Epub 2011 May 15.

3.

New oral anticoagulants: should they replace heparins and warfarin?

Tsiara S, Pappas K, Boutsis D, Laffan M.

Hellenic J Cardiol. 2011 Jan-Feb;52(1):52-67. Review. No abstract available.

4.

CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.

Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M, Georgiou I, Bourantas KL.

Leuk Res. 2010 Feb;34(2):148-53. doi: 10.1016/j.leukres.2009.06.019.

PMID:
19595458
5.

Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.

Hatzimichael E, Benetatos L, Dasoula A, Dranitsaris G, Tsiara S, Georgiou I, Syrrou M, Stebbing J, Coley HM, Crook T, Bourantas KL.

Leuk Res. 2009 Sep;33(9):1272-5. doi: 10.1016/j.leukres.2009.04.009. Epub 2009 May 6.

PMID:
19423161
6.

Multiple complete remissions over a period of 6 years in a patient with acute myeloid leukemia after intensive chemotherapy.

Tsabouri S, Alimara V, Tsiara S, Vassiou A, Bourantas KL.

Leuk Lymphoma. 2007 Jan;48(1):187-9. No abstract available.

PMID:
17325865
7.

Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.

Tsiara SN, Chaidos A, Bourantas LK, Kapsali HD, Bourantas KL.

Acta Haematol. 2007;117(3):156-61. Epub 2006 Dec 6.

PMID:
17159338
8.

A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.

Alymara V, Tzouvara E, Vartholomatos G, Chaidos A, Tsiara S, Bourantas KL.

J Exp Clin Cancer Res. 2004 Sep;23(3):447-54.

PMID:
15595635
9.

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Acta Haematol. 2004;111(4):189-95.

PMID:
15153710
10.

Treatment of resistant/relapsing chronic lymphocytic leukemia with a combination regimen containing deoxycoformycin and rituximab.

Tsiara SN, Kapsali HD, Chaidos A, Christou L, Bourantas KL.

Acta Haematol. 2004;111(4):185-8.

PMID:
15153709
11.

Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.

Tsiara SN, Chaidos A, Gouva M, Christou L, Panteli K, Kapsali E, Bourantas KL.

J Exp Clin Cancer Res. 2004 Mar;23(1):47-52.

PMID:
15149150
12.

Early vascular benefits of statin therapy.

Tsiara S, Elisaf M, Mikhailidis DP.

Curr Med Res Opin. 2003;19(6):540-56. Review.

PMID:
14594527
13.

Influence of smoking on predictors of vascular disease.

Tsiara S, Elisaf M, Mikhailidis DP.

Angiology. 2003 Sep-Oct;54(5):507-30. Review.

PMID:
14565627
14.

Platelets as predictors of vascular risk: is there a practical index of platelet activity?

Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP.

Clin Appl Thromb Hemost. 2003 Jul;9(3):177-90. Review.

PMID:
14507105
15.

Mean platelet volume as an indicator of platelet activation: methodological issues.

Jagroop IA, Tsiara S, Mikhailidis DP.

Platelets. 2003 Aug;14(5):335-6. No abstract available.

PMID:
12944252
16.

Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature.

Briasoulis E, Tzouvara E, Tsiara S, Vartholomatos G, Tsekeris P, Bourantas K.

Breast J. 2003 May-Jun;9(3):241-5. Review.

PMID:
12752636
17.

Thalidomide administration for the treatment of resistant plasma cell leukemia.

Tsiara S, Chaidos A, Kapsali H, Tzouvara E, Bourantas KL.

Acta Haematol. 2003;109(3):153-5. No abstract available.

PMID:
12747371
18.

Unexplained hypertransaminasaemia: clue to diagnosis of Addison's disease.

Milionis HJ, Dimos GA, Tsiara S, Tsatsoulis A, Tsianos EV, Elisaf MS.

Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1285-6. No abstract available.

PMID:
12439129
19.

Solitary bone plasmacytoma in a young patient.

Panteli K, Tsiara S, Bourantas KL.

J Exp Clin Cancer Res. 2002 Mar;21(1):139-41.

PMID:
12071521
20.

Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone.

Christou L, Hatzimichael E, Chaidos A, Tsiara S, Bourantas KL.

Eur J Haematol. 2001 Jul;67(1):51-3.

PMID:
11553267

Supplemental Content

Loading ...
Support Center